APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diclofenac Sodium Sustained-Release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diclofenac Sodium Sustained-Release Capsules Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchDiclofenac Sodium Sustained-Release Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Diclofenac Sodium Sustained-Release Capsules Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Diclofenac Sodium Sustained-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diclofenac Sodium Sustained-Release Capsules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Diclofenac Sodium Sustained-Release Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Diclofenac Sodium Sustained-Release Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diclofenac Sodium Sustained-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diclofenac Sodium Sustained-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diclofenac Sodium Sustained-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diclofenac Sodium Sustained-Release Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diclofenac Sodium Sustained-Release Capsules market include Chang'ao Pharmaceutical, China Pharmaceutical University Pharmaceutical, Rundu Pharmaceutical, Nucien Pharmaceutical, Yiheng Pharmaceutical, Hengshan Pharmaceutical, Furen Group Pharmaceutical, Buchang Pharmaceutical and TNJ Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diclofenac Sodium Sustained-Release Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diclofenac Sodium Sustained-Release Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diclofenac Sodium Sustained-Release Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diclofenac Sodium Sustained-Release Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Diclofenac Sodium Sustained-Release Capsules Segment by Company

Chang'ao Pharmaceutical

China Pharmaceutical University Pharmaceutical

Rundu Pharmaceutical

Nucien Pharmaceutical

Yiheng Pharmaceutical

Hengshan Pharmaceutical

Furen Group Pharmaceutical

Buchang Pharmaceutical

TNJ Chemical

Simcere Pharmaceutical

Dexcel Pharma

Bestochem

Diclofenac Sodium Sustained-Release Capsules Segment by Type

Specification 0.25g

Specification 0.5g

Diclofenac Sodium Sustained-Release Capsules Segment by Application

Hospital

Clinic

Diclofenac Sodium Sustained-Release Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diclofenac Sodium Sustained-Release Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diclofenac Sodium Sustained-Release Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diclofenac Sodium Sustained-Release Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Diclofenac Sodium Sustained-Release Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diclofenac Sodium Sustained-Release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diclofenac Sodium Sustained-Release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diclofenac Sodium Sustained-Release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diclofenac Sodium Sustained-Release Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diclofenac Sodium Sustained-Release Capsules industry.

Chapter 3: Detailed analysis of Diclofenac Sodium Sustained-Release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diclofenac Sodium Sustained-Release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diclofenac Sodium Sustained-Release Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diclofenac Sodium Sustained-Release Capsules Industry Trends Table 2. Diclofenac Sodium Sustained-Release Capsules Industry Drivers Table 3. Diclofenac Sodium Sustained-Release Capsules Industry Opportunities and Challenges Table 4. Diclofenac Sodium Sustained-Release Capsules Industry Restraints Table 5. Global Diclofenac Sodium Sustained-Release Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diclofenac Sodium Sustained-Release Capsules Revenue Share by Company (2021-2026) Table 7. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Company (k units) & (2021-2026) Table 8. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Diclofenac Sodium Sustained-Release Capsules Average Price (US$/unit) of Company (2021-2026) Table 10. Global Diclofenac Sodium Sustained-Release Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diclofenac Sodium Sustained-Release Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Diclofenac Sodium Sustained-Release Capsules Company, Product Type & Application Table 13. Global Diclofenac Sodium Sustained-Release Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diclofenac Sodium Sustained-Release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Specification 0.25g Table 18. Significant Companies of Specification 0.5g Table 19. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type (2021-2026) & (k units) Table 21. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type (2027-2032) & (k units) Table 22. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type (2021-2026) Table 28. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application (2021-2026) & (k units) Table 33. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application (2027-2032) & (k units) Table 34. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Application (2021-2026) Table 35. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Application (2027-2032) Table 36. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application (2021-2026) Table 40. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application (2027-2032) Table 41. Global Diclofenac Sodium Sustained-Release Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Diclofenac Sodium Sustained-Release Capsules Sales by Region (2021-2026) & (k units) Table 43. Global Diclofenac Sodium Sustained-Release Capsules Sales Market Share by Region (2021-2026) Table 44. Global Diclofenac Sodium Sustained-Release Capsules Sales by Region (2027-2032) & (k units) Table 45. Global Diclofenac Sodium Sustained-Release Capsules Sales Market Share by Region (2027-2032) Table 46. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Region (2021-2026) Table 49. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Region (2027-2032) Table 51. Global Diclofenac Sodium Sustained-Release Capsules Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Diclofenac Sodium Sustained-Release Capsules Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Diclofenac Sodium Sustained-Release Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Diclofenac Sodium Sustained-Release Capsules Sales by Country (2021-2026) & (k units) Table 56. Global Diclofenac Sodium Sustained-Release Capsules Sales Market Share by Country (2021-2026) Table 57. Global Diclofenac Sodium Sustained-Release Capsules Sales by Country (2027-2032) & (k units) Table 58. Global Diclofenac Sodium Sustained-Release Capsules Sales Market Share by Country (2027-2032) Table 59. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Market Share by Country (2021-2026) Table 61. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Market Share by Country (2027-2032) Table 63. Chang'ao Pharmaceutical Company Information Table 64. Chang'ao Pharmaceutical Business Overview Table 65. Chang'ao Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Chang'ao Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 67. Chang'ao Pharmaceutical Recent Development Table 68. China Pharmaceutical University Pharmaceutical Company Information Table 69. China Pharmaceutical University Pharmaceutical Business Overview Table 70. China Pharmaceutical University Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. China Pharmaceutical University Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 72. China Pharmaceutical University Pharmaceutical Recent Development Table 73. Rundu Pharmaceutical Company Information Table 74. Rundu Pharmaceutical Business Overview Table 75. Rundu Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Rundu Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 77. Rundu Pharmaceutical Recent Development Table 78. Nucien Pharmaceutical Company Information Table 79. Nucien Pharmaceutical Business Overview Table 80. Nucien Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Nucien Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 82. Nucien Pharmaceutical Recent Development Table 83. Yiheng Pharmaceutical Company Information Table 84. Yiheng Pharmaceutical Business Overview Table 85. Yiheng Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Yiheng Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 87. Yiheng Pharmaceutical Recent Development Table 88. Hengshan Pharmaceutical Company Information Table 89. Hengshan Pharmaceutical Business Overview Table 90. Hengshan Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Hengshan Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 92. Hengshan Pharmaceutical Recent Development Table 93. Furen Group Pharmaceutical Company Information Table 94. Furen Group Pharmaceutical Business Overview Table 95. Furen Group Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Furen Group Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 97. Furen Group Pharmaceutical Recent Development Table 98. Buchang Pharmaceutical Company Information Table 99. Buchang Pharmaceutical Business Overview Table 100. Buchang Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Buchang Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 102. Buchang Pharmaceutical Recent Development Table 103. TNJ Chemical Company Information Table 104. TNJ Chemical Business Overview Table 105. TNJ Chemical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. TNJ Chemical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 107. TNJ Chemical Recent Development Table 108. Simcere Pharmaceutical Company Information Table 109. Simcere Pharmaceutical Business Overview Table 110. Simcere Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Simcere Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 112. Simcere Pharmaceutical Recent Development Table 113. Dexcel Pharma Company Information Table 114. Dexcel Pharma Business Overview Table 115. Dexcel Pharma Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Dexcel Pharma Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 117. Dexcel Pharma Recent Development Table 118. Bestochem Company Information Table 119. Bestochem Business Overview Table 120. Bestochem Diclofenac Sodium Sustained-Release Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Bestochem Diclofenac Sodium Sustained-Release Capsules Product Portfolio Table 122. Bestochem Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Diclofenac Sodium Sustained-Release Capsules Distributors List Table 126. Diclofenac Sodium Sustained-Release Capsules Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Diclofenac Sodium Sustained-Release Capsules Product Image Figure 2. Global Diclofenac Sodium Sustained-Release Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diclofenac Sodium Sustained-Release Capsules Sales (2021-2032) & (k units) Figure 5. Global Diclofenac Sodium Sustained-Release Capsules Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Diclofenac Sodium Sustained-Release Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Specification 0.25g Image Figure 10. Specification 0.5g Image Figure 11. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Application (2021-2032) Figure 22. Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application (2021-2032) Figure 25. Global Diclofenac Sodium Sustained-Release Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Diclofenac Sodium Sustained-Release Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 30. North America Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. South America Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Diclofenac Sodium Sustained-Release Capsules Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Diclofenac Sodium Sustained-Release Capsules Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Specification 0.25g
  • Specification 0.5g
Applications
  • Hospital
  • Clinic
Companies covered
  • Chang'ao Pharmaceutical
  • China Pharmaceutical University Pharmaceutical
  • Rundu Pharmaceutical
  • Nucien Pharmaceutical
  • Yiheng Pharmaceutical
  • Hengshan Pharmaceutical
  • Furen Group Pharmaceutical
  • Buchang Pharmaceutical
  • TNJ Chemical
  • Simcere Pharmaceutical
  • Dexcel Pharma
  • Bestochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diclofenac Sodium Sustained-Release Capsules Market Dynamics
  1. 2.1 Diclofenac Sodium Sustained-Release Capsules Industry Trends
  2. 2.2 Diclofenac Sodium Sustained-Release Capsules Industry Drivers
  3. 2.3 Diclofenac Sodium Sustained-Release Capsules Industry Opportunities and Challenges
  4. 2.4 Diclofenac Sodium Sustained-Release Capsules Industry Restraints
3 Diclofenac Sodium Sustained-Release Capsules Market by Company
  1. 3.1 Global Diclofenac Sodium Sustained-Release Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Diclofenac Sodium Sustained-Release Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Diclofenac Sodium Sustained-Release Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Diclofenac Sodium Sustained-Release Capsules Company Ranking (2024-2026)
  6. 3.6 Global Diclofenac Sodium Sustained-Release Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Diclofenac Sodium Sustained-Release Capsules Company Product Type and Application
  8. 3.8 Global Diclofenac Sodium Sustained-Release Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diclofenac Sodium Sustained-Release Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diclofenac Sodium Sustained-Release Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diclofenac Sodium Sustained-Release Capsules Market by Type
  1. 4.1 Diclofenac Sodium Sustained-Release Capsules Type Introduction
  2. 4.1.1 Specification 0.25g
  3. 4.1.2 Specification 0.5g
  4. 4.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type
  5. 4.2.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type
  9. 4.3.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type (2021-2032)
5 Diclofenac Sodium Sustained-Release Capsules Market by Application
  1. 5.1 Diclofenac Sodium Sustained-Release Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application
  5. 5.2.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application
  9. 5.3.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Application (2021-2032)
  11. 5.3.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application (2021-2032)
6 Diclofenac Sodium Sustained-Release Capsules Regional Sales and Value Analysis
  1. 6.1 Global Diclofenac Sodium Sustained-Release Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diclofenac Sodium Sustained-Release Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Diclofenac Sodium Sustained-Release Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Diclofenac Sodium Sustained-Release Capsules Sales by Region (2027-2032)
  5. 6.3 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Diclofenac Sodium Sustained-Release Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diclofenac Sodium Sustained-Release Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Country, 2025 VS 2032
7 Diclofenac Sodium Sustained-Release Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Diclofenac Sodium Sustained-Release Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diclofenac Sodium Sustained-Release Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Diclofenac Sodium Sustained-Release Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Diclofenac Sodium Sustained-Release Capsules Sales by Country (2027-2032)
  6. 7.4 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diclofenac Sodium Sustained-Release Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diclofenac Sodium Sustained-Release Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chang'ao Pharmaceutical
  2. 8.1.1 Chang'ao Pharmaceutical Company Information
  3. 8.1.2 Chang'ao Pharmaceutical Business Overview
  4. 8.1.3 Chang'ao Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chang'ao Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  6. 8.1.5 Chang'ao Pharmaceutical Recent Developments
  7. 8.2 China Pharmaceutical University Pharmaceutical
  8. 8.2.1 China Pharmaceutical University Pharmaceutical Company Information
  9. 8.2.2 China Pharmaceutical University Pharmaceutical Business Overview
  10. 8.2.3 China Pharmaceutical University Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 China Pharmaceutical University Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  12. 8.2.5 China Pharmaceutical University Pharmaceutical Recent Developments
  13. 8.3 Rundu Pharmaceutical
  14. 8.3.1 Rundu Pharmaceutical Company Information
  15. 8.3.2 Rundu Pharmaceutical Business Overview
  16. 8.3.3 Rundu Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Rundu Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  18. 8.3.5 Rundu Pharmaceutical Recent Developments
  19. 8.4 Nucien Pharmaceutical
  20. 8.4.1 Nucien Pharmaceutical Company Information
  21. 8.4.2 Nucien Pharmaceutical Business Overview
  22. 8.4.3 Nucien Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nucien Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  24. 8.4.5 Nucien Pharmaceutical Recent Developments
  25. 8.5 Yiheng Pharmaceutical
  26. 8.5.1 Yiheng Pharmaceutical Company Information
  27. 8.5.2 Yiheng Pharmaceutical Business Overview
  28. 8.5.3 Yiheng Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yiheng Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  30. 8.5.5 Yiheng Pharmaceutical Recent Developments
  31. 8.6 Hengshan Pharmaceutical
  32. 8.6.1 Hengshan Pharmaceutical Company Information
  33. 8.6.2 Hengshan Pharmaceutical Business Overview
  34. 8.6.3 Hengshan Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hengshan Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  36. 8.6.5 Hengshan Pharmaceutical Recent Developments
  37. 8.7 Furen Group Pharmaceutical
  38. 8.7.1 Furen Group Pharmaceutical Company Information
  39. 8.7.2 Furen Group Pharmaceutical Business Overview
  40. 8.7.3 Furen Group Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Furen Group Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  42. 8.7.5 Furen Group Pharmaceutical Recent Developments
  43. 8.8 Buchang Pharmaceutical
  44. 8.8.1 Buchang Pharmaceutical Company Information
  45. 8.8.2 Buchang Pharmaceutical Business Overview
  46. 8.8.3 Buchang Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Buchang Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  48. 8.8.5 Buchang Pharmaceutical Recent Developments
  49. 8.9 TNJ Chemical
  50. 8.9.1 TNJ Chemical Company Information
  51. 8.9.2 TNJ Chemical Business Overview
  52. 8.9.3 TNJ Chemical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 TNJ Chemical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  54. 8.9.5 TNJ Chemical Recent Developments
  55. 8.10 Simcere Pharmaceutical
  56. 8.10.1 Simcere Pharmaceutical Company Information
  57. 8.10.2 Simcere Pharmaceutical Business Overview
  58. 8.10.3 Simcere Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Simcere Pharmaceutical Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  60. 8.10.5 Simcere Pharmaceutical Recent Developments
  61. 8.11 Dexcel Pharma
  62. 8.11.1 Dexcel Pharma Company Information
  63. 8.11.2 Dexcel Pharma Business Overview
  64. 8.11.3 Dexcel Pharma Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Dexcel Pharma Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  66. 8.11.5 Dexcel Pharma Recent Developments
  67. 8.12 Bestochem
  68. 8.12.1 Bestochem Company Information
  69. 8.12.2 Bestochem Business Overview
  70. 8.12.3 Bestochem Diclofenac Sodium Sustained-Release Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bestochem Diclofenac Sodium Sustained-Release Capsules Product Portfolio
  72. 8.12.5 Bestochem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diclofenac Sodium Sustained-Release Capsules Value Chain Analysis
  2. 9.1.1 Diclofenac Sodium Sustained-Release Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diclofenac Sodium Sustained-Release Capsules Sales Mode & Process
  6. 9.2 Diclofenac Sodium Sustained-Release Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diclofenac Sodium Sustained-Release Capsules Distributors
  9. 9.2.3 Diclofenac Sodium Sustained-Release Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst